Pathological complete response in pancreatic adenocarcinoma with FOLFIRINOX.
| Autor: | Kao CT; Internal Medicine/Medical Oncology, University of Kansas, Kansas City, Kansas, USA., Aziz M; Internal Medicine/Medical Oncology, University of Kansas, Kansas City, Kansas, USA., Kasi A; Internal Medicine/Medical Oncology, University of Kansas, Kansas City, Kansas, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | BMJ case reports [BMJ Case Rep] 2018 Sep 01; Vol. 2018. Date of Electronic Publication: 2018 Sep 01. |
| DOI: | 10.1136/bcr-2018-225621 |
| Abstrakt: | The report describes a patient who presented to our centre with abdominal pain and significant weight loss due to adenocarcinoma of the tail of the pancreas. The cancer was deemed as 'resectable disease associated with morbid surgical outcomes' due to the local involvement of the vessels and adjacent organs. Given the patient's excellent performance status, the patient underwent neoadjuvant chemotherapy with folinic acid, fluorouracil, irinotecan and oxaliplatin to downstage the tumour for less morbid surgical resection. The patient underwent 12 cycles of chemotherapy with serial imaging which demonstrated positive response to treatment and surgical resection was performed. Surgical pathology revealed no residual tumour and imaging was negative for any extrapancreatic tumour metastasis. This is an unusual case as pancreatic malignancy is usually lethal with poor survival outcomes. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|